[HTML][HTML] Utilization and perceptions of hydroxyurea therapy among adult patients with sickle cell disease in Al Ahsa, Saudi Arabia: a cross-sectional study
IH Alherz, ZJ Al-Nass, MA Alkadi - Cureus, 2024 - pmc.ncbi.nlm.nih.gov
Background: Sickle cell disease (SCD) is a prevalent genetic disorder characterized by
abnormal hemoglobin formation, resulting in severe complications. Hydroxyurea (HU) …
abnormal hemoglobin formation, resulting in severe complications. Hydroxyurea (HU) …
Attributional Style and Hydroxyurea Adherence in Adults With Sickle Cell Disease
L Archer - 2024 - search.proquest.com
Sickle cell disease (SCD) is known to cause significant morbidity, early mortality, and poor
health-related quality of life. Hydroxyurea is an approved drug therapy that reduces vaso …
health-related quality of life. Hydroxyurea is an approved drug therapy that reduces vaso …
Ingesta diaria de líquidos y uso de hidroxiurea en pacientes con enfermedad falciforme de un centro de referencia de Cartagena de Indias, Colombia
OGI Jiménez, RMS Merlano - Revista colombiana de hematología y …, 2024 - revista.acho.info
En la enfermedad falciforme (EF) la ingesta de líquidos es determinante porque la
deshidratación incrementa la polimerización de la HbS y la aparición de crisis …
deshidratación incrementa la polimerización de la HbS y la aparición de crisis …